Jubilant Life Sciences, an integrated pharma and life sciences company, announced that the company has issued commercial papers for an aggregate amount of Rs 500 million on October 14, 2016, having maturity date of December 20, 2016, which have been rated IND A1+ by India Ratings & Research Private.

The aggregate amount of commercial papers outstanding as on date is Rs. 500 million.

The stock had outperformed the market over the past one month till Oct. 13, 2016, rising 14.11% compared with the Sensex's 2.51% decline. It outperformed the market in past one quarter, gaining 104.76% as against 0.62% fall in the Sensex.

Shares of the company gained Rs 2.4, or 0.37%, to trade at Rs 645.45. The total volume of shares traded was 100,705 at the BSE (2.46 p.m., Friday).